Human papilloma virus has a clearly demonstrated role in cervical and head and neck cancers, but viral etiology for other solid tumors is less well understood. To expand this area of research, we obtained and analyzed the immune receptor recombinations available from both blood and tumor samples, through mining of exome files produced from those sources, for 32 cancer types represented by the cancer genome atlas (TCGA). Among TCGA data sets, the recovery frequency for antiviral complementarity determining region-3 sequences (CDR3s), for T cell receptor-alpha and T cell receptor-beta, ranged from 0% to 21% of the patients, for the different cancer types, with breast, lung, pancreatic, and thymus cancers representing the highest of that range, particularly for tumor tissue resident T cells. In several cases, recovery of the antiviral CDR3s associated with distinct survival rates, and in all of these cases, the recovery of an antiviral CDR3 associated with a worse survival rate.
Get full access to this article
View all access options for this article.
References
1.
BishopRK, Valle OsegueraCA, and SpencerJV. Human Cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells. Cancer Cell Microenviron, 2015; 2:e678.
2.
BoschFX, LorinczA, MunozN, et al.The causal relation between human papilloma virus and cervical cancer. J Clin Pathol, 2002; 55:244–265.
3.
CalabroML, and SaridR. Human herpesvirus 8 and lymphoproliferative disorders. Mediterr J Hematol Infect Dis, 2018; 10:e2018061.
4.
CallahanBM, TongWL, and BlanckG. T cell receptor-beta J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates. Immunol Res, 2018; 66:219–223.
5.
CallahanBM, YavorskiJM, TuYN, et al.T-cell receptor-beta V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. Cancer Immunol Immunother, 2018; 67:885–892.
6.
CantalupoPG, KatzJP, and PipasJM. Viral sequences in human cancer. Virology, 2018; 513:208–216.
7.
CeramiE, GaoJ, DogrusozU, et al.The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov, 2012; 2:401–404.
8.
ChobrutskiyBI, ZamanS, TongWL, et al.Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol, 2018; 140:697–704.
9.
DochezC, BogersJJ, VerhelstR, et al.HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine, 2014; 32:1595–1601.
10.
DulaiPS, SandbornWJ, and GuptaS. Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology, and management. Cancer Prevent Res, 2016; 9:887–894.
11.
El-SharkawyA, Al ZaidanL, and MalkiA. Epstein-Barr Virus-associated malignancies: roles of viral oncoproteins in carcinogenesis. Front Oncol, 2018; 8:265.
12.
GaoJ, AksoyBA, DogrusozU, et al.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal, 2013; 6:pl1.
13.
GellerLT, Barzily-RokniM, DaninoT, et al.Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science, 2017; 357:1156–1160.
14.
KiezunA, GarimellaK, DoR, et al.Exome sequencing and the genetic basis of complex traits. Nat Genet, 2012; 44:623–630.
15.
KinskeyJC, TuYN, TongWL, et al.Recovery of Immunoglobulin VJ recombinations from pancreatic cancer exome files strongly correlates with reduced survival. Cancer Microenviron, 2018; 11:51–59.
16.
MaiAT, TongWL, TuYN, et al.TcR-alpha recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers. Int Immunol, 2018; 30:35–40.
17.
McLarenPJ, PulitSL, GurdasaniD, et al.Evaluating the impact of functional genetic variation on HIV-1 control. J Infect Dis, 2017; 216:1063–1069.
18.
PadovanE, CasoratiG, DellabonaP, et al.Expression of two T cell receptor alpha chains: dual receptor T cells. Science, 1993; 262:422–424.
19.
ParrishRA, KarstenMB, McRaeAT, et al.Segmental Crohn's colitis associated with adenocarcinoma. Am J Surg, 1968; 115:371–375.
20.
PrabhuSR, and WilsonDF. Evidence of epstein-barr virus association with head and neck cancers: a review. J Can Dent Assoc, 2016; 82:g2.
21.
RichardsonAK, CoxB, McCredieMR, et al.Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer, 2004; 90:2149–2152.
22.
RichardsonAK, CurrieMJ, RobinsonBA, et al.Cytomegalovirus and Epstein-Barr virus in breast cancer. PLoS One, 2015; 10:e0118989.
23.
RosatoPC, WijeyesingheS, StolleyJM, et al.Virus-specific memory T cells populate tumors and can be repurposed for tumor immunotherapy. Nat Commun, 2019; 10:567.
24.
SamyMD, TongWL, YavorskiJM, et al.T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-beta VDJ recombinations associates with a favorable oncologic outcome for bladder cancer. Cancer Immunol Immunother, 2017; 66:403–410.
25.
ScheperW, KeldermanS, FanchiLF, et al.Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med, 2019; 25:89–94.
26.
ShugayM, BagaevDV, ZvyaginIV, et al.VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res, 2018; 46:D419–D427.
27.
SimoniY, BechtE, FehlingsM, et al.Bystander CD8(+) T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature, 2018; 557:575–579.
28.
TickotskyN, SagivT, PriluskyJ, et al.McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics, 2017; 33:2924–2929.
29.
TongWL, CallahanBM, TuYN, et al.Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates. Breast Cancer Res Treat, 2018; 173:167–177.
30.
TongWL, TuYN, SamyMD, et al.Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: evidence for high level B-cell infiltrates in breast cancer. Hum Vaccin Immunother, 2017; 13:501–506.
31.
TuYN, TongWL, SamyMD, et al.Assessing microenvironment immunogenicity using tumor specimen exomes: co-detection of TcR-alpha/beta V(D)J recombinations correlates with PD-1 expression. Int J Cancer, 2017; 140:2568–2576.
32.
TuYN, TongWL, YavorskiJM, et al.Immunogenomics: a negative prostate cancer outcome associated with TcR-gamma/delta recombinations. Cancer Microenviron, 2018; 11:41–49.
33.
WestbrookAM, SzakmaryA, and SchiestlRH. Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models. Mutat Res, 2010; 705:40–59.
34.
ZamanS, ChobrutskiyBI, PatelJS, et al.Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme. Biochem Biophys Res Commun, 2018; 503:2218–2225.
35.
ZamanS, ChobrutskiyBI, PatelJS, et al.MMP7 sensitivity of mutant ECM proteins: an indicator of melanoma survival rates and T-cell infiltration. Clin Biochem, 2018; 63:85–91.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
